🇺🇸 FDA
Pipeline program

ISA101b

ISA101b-HN-01-17

Phase 2 mab active

Quick answer

ISA101b for Squamous Cell Carcinoma of the Oropharynx is a Phase 2 program (mab) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Squamous Cell Carcinoma of the Oropharynx
Phase
Phase 2
Modality
mab
Status
active

Clinical trials